Relevant bibliographies by topics / Advanced prostatic carcinoma

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Advanced prostatic carcinoma'

Author: Grafiati
Published: 4 June 2025
Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Advanced prostatic carcinoma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Advanced prostatic carcinoma"

1

Kozlowski, James M., William J. Ellis, and John T. Grayhack. "Advanced Prostatic Carcinoma." Urologic Clinics of North America 18, no. 1 (1991): 15–24. http://dx.doi.org/10.1016/s0094-0143(21)01389-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rasool, Mumtaz, Shafiq Ahmad Iqbal, Mudassar Saeed Pansota, Shafqat Ali Tabassum, and Iftikhar Ahmad. "PROSTATIC CARCINOMA." Professional Medical Journal 22, no. 06 (2015): 710–14. http://dx.doi.org/10.29309/tpmj/2015.22.06.1236.

Full text
Abstract:
Introduction: During the past many years the availability of serum PSAas a screening marker, has encouraged its use to diagnose both prostatic cancer and itsrecurrence. Patients with high S/PSA are at increased risk of advanced carcinoma prostate andscreening at an earlier stage would help to manage it accordingly. The aim of this study wasto determine association between serum prostatic specific antigen (PSA) levels and Gleasongrade in prostatic carcinoma patients. Study Design: Descriptive, case series study. Setting:Department of Urology & Renal Transplantation in collaboration with Ins
APA, Harvard, Vancouver, ISO, and other styles
3

HARNETT, P. R., D. RAGHAVAN, I. CATERSON, et al. "Aminoglutethimide in Advanced Prostatic Carcinoma." British Journal of Urology 59, no. 4 (1987): 323–27. http://dx.doi.org/10.1111/j.1464-410x.1987.tb04641.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Apple, J. S., D. F. Paulson, C. Baber, and C. E. Putman. "Advanced prostatic carcinoma: pulmonary manifestations." Radiology 154, no. 3 (1985): 601–4. http://dx.doi.org/10.1148/radiology.154.3.2578678.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kuban, Deborah A., Paul F. Schellhammer, and Anas M. El-Mahdi. "Hemibody Irradiation in Advanced Prostatic Carcinoma." Urologic Clinics of North America 18, no. 1 (1991): 131–37. http://dx.doi.org/10.1016/s0094-0143(21)01400-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Biers, Suzanne M., Mark E. Sullivan, Ian S. D. Roberts, and Jeremy G. Noble. "Thrombotic microangiopathy in advanced prostatic carcinoma." Urology 63, no. 2 (2004): 380–82. http://dx.doi.org/10.1016/j.urology.2003.09.069.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ruff, P., D. P. Derman, A. Weaving, and W. R. Bezwoda. "Systemic treatment of advanced prostatic carcinoma." Journal of Steroid Biochemistry 28 (January 1987): 82. http://dx.doi.org/10.1016/0022-4731(87)91339-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Seftel, Allen D., J. Patrick Spirnak, and Martin I. Resnick. "Hormonal Therapy for Advanced Prostatic Carcinoma." Journal of Surgical Oncology 42, S1 (1989): 14–20. http://dx.doi.org/10.1002/jso.2930420505.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Goktas, S., A. Ziada, and ED Crawford. "Combined androgen blockade for advanced prostatic carcinoma." Prostate Cancer and Prostatic Diseases 2, no. 4 (1999): 172–79. http://dx.doi.org/10.1038/sj.pcan.4500323.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kayigil, Ö., Ö. Atahan, and A. Metin. "Cyproterone acetate monotherapy in advanced prostatic carcinoma." International Urology and Nephrology 29, no. 2 (1997): 213–20. http://dx.doi.org/10.1007/bf02551344.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Advanced prostatic carcinoma"

1

Cyrta, Joanna. "A Pleiotropic Role of the SWI/SNF Complex in Cancer – Insights From Two Tumor Types : Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Prostatic Carcinoma Role of Specialized Composition of SWI/SNF Complexes in Prostate Cancer Lineage Genomic Correlates of Clinical Outcome in Advanced Prostate Cancer." Thesis, université Paris-Saclay, 2020. http://www.theses.fr/2020UPASL045.

Full text
Abstract:
Le complexe de remodelage de la chromatine SWI/SNF est un régulateur épigénétique majeur impliqué dans le développement embryonnaire et dans la différentiation cellulaire. De plus, les gènes qui encodent les sous-unités de SWI/SNF sont altérés dans au moins 20% de cancers. Bien que le complexe SWI/SNF soit le plus souvent considéré comme suppresseur des tumeurs, il existe des preuves croissantes que le rôle de SWI/SNF dans le cancer peut dépendre du type de tissu et du contexte.Dans la première partie de cette dissertation, nous présentons la caractérisation moléculaire d’une cohorte indépenda
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Advanced prostatic carcinoma"

1

V, D'Amico Anthony, and Hanks Gerald E, eds. Advances in the radiotherapeutic management of carcinoma of the prostate. Chapman & Hall, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

(Editor), Anthony V. D'Amico, and Gerald E. Hanks (Editor), eds. Advances in the Radiotherapeutic Management of Carcinoma of the Prostate. Oxford Univ Pr (Txt), 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Thun, Michael J., and Neal D. Freedman. Tobacco. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0011.

Full text
Abstract:
Tobacco is the leading preventable cause of cancer and other non-communicable diseases worldwide. IARC and the U.S. Surgeon General designate over twenty cancer sites or subsites as causally related to active cigarette smoking, including lung, oral cavity, nasal cavity and accessory sinuses, naso- oro- and hypopharynx, larynx, esophagus (squamous cell carcinoma and adenocarcinoma), stomach, pancreas, colorectum, liver, kidney (adeno- and transitional cell carcinoma), ureter, urinary bladder, uterine cervix, ovary (mucinous), and acute myeloid leukemia. Even this list may be incomplete, as it d
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Advanced prostatic carcinoma"

1

Lotti, T., V. Altieri, V. Mirone, N. Ottaviano, and A. Russo. "Local Hyperthermia for Treatment of Advanced Prostatic Carcinoma: Preliminary Results." In Advances in Experimental Medicine and Biology. Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5766-7_57.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sogani, Pramod C., and Willet F. Whitmore. "Flutamide and Other Antiandrogens in the Treatment of Advanced Prostatic Carcinoma." In Cancer Treatment and Research. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1731-9_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nagel, R., H. Al-Abadi, and V. Borgmann. "Results of the Treatment of Locally Advanced Prostatic Carcinoma with LH-RH Analogues." In LH-RH Agonists in Oncology. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73530-1_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Comaru-Schally, A. M. "Analogs of Luteinizing Hormone-releasing Hormone in Benign Prostatic Hyperplasia and Advanced Renal Cell Carcinoma." In Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance. Springer Milan, 2003. http://dx.doi.org/10.1007/978-88-470-2085-6_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jacobi, G. H., U. K. Wenderoth, H. v. Wallenberg, M. Gatto, and R. Hohenfellner. "LH-RH Analogues for Palliation of Advanced Prostatic Carcinoma. A Critical Review After Five Years of Experience." In LH-RH Agonists in Oncology. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73530-1_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Koiso, Kenkichi, and Tatsuo Iizumi. "A Model for Studies on Human Prostatic Carcinoma." In Advances in Experimental Medicine and Biology. Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3398-6_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Daneshgari, M. D. Firouz, E. David Crawford, B. A. Susan, and A. Majeski. "Etoposide in treatment of hormone refractory advanced carcinoma of the prostate." In Cancer Treatment An Update. Springer Paris, 1994. http://dx.doi.org/10.1007/978-2-8178-0765-2_115.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Shirai, Tomoyuki, Seiko Tamano, Satoru Takahashi, and Nobuyuki Ito. "Animal Prostate Carcinoma Models: Limited Potential for Vertebral Metastasis." In Advances in Experimental Medicine and Biology. Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3398-6_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tsukamoto, Taiji, Yoshiaki Kumamoto, Tsugio Umehara, et al. "Clinical Study of Bone-Related Relapse in Prostate Carcinoma." In Advances in Experimental Medicine and Biology. Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3398-6_31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Furusato, Masakuni, William C. Allsbrook, Hiroyuki Kato, et al. "Flow Cytometric Analysis of Prostatic Carcinoma with and without Bone Marrow Metastasis." In Advances in Experimental Medicine and Biology. Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3398-6_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Advanced prostatic carcinoma"

1

Gangar, Subhash Chander, Gagan Deep, and Rajesh Agarwal. "Abstract 5661: Silibinin inhibits advanced human prostate carcinoma-induced osteoclastogenesis." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-5661.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nuñez, Muriel A., Javier Cerda-Infante, Marianela Sánchez, Paula Sotomayor, Alejandro S. Godoy, and Viviana P. Montecinos. "Abstract B007: Stemness features of prostate cancer cells induced by carcinoma-associated fibroblasts." In Abstracts: AACR Special Conference: Prostate Cancer: Advances in Basic, Translational, and Clinical Research; December 2-5, 2017; Orlando, Florida. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.prca2017-b007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Krafft, Christoph, Eric Boateng Osei, Jürgen Popp, and Irina Nazarenko. "Raman and SERS spectroscopy for characterization of extracellular vesicles from control and prostate carcinoma patients." In Biomedical Vibrational Spectroscopy 2020: Advances in Research and Industry, edited by Wolfgang Petrich and Zhiwei Huang. SPIE, 2020. http://dx.doi.org/10.1117/12.2549209.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Banck, Michaela S., Rashmi Chugh, Ronald B. Natale, et al. "Abstract A55: Phase 1 results of emibetuzumab (LY2875358), a bivalent MET antibody, in patients with advanced castration-resistant prostate cancer, and MET positive renal cell carcinoma, non-small cell lung cancer, and hepatocellular carcinoma." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1535-7163.targ-15-a55.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Corrêa, Tatiana Strava, Renata Lazari Sandoval, Luiza Nardin Weis, Ana Carolina Rathsam Leite, and Romualdo Barroso de Sousa. "LACK OF ACCESS TO GENETIC TESTING AMONG PATIENTS AT RISK OF HEREDITARY BREAST CANCER IN THE BRAZILIAN PUBLIC HEALTH SYSTEM." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2064.

Full text
Abstract:
Objectives: In Brazil, patients treated in the public health (PH) system have no access to genetic testing. This study aims to explore the clinical profile of patients at risk of hereditary breast cancer (BC) in a tertiary hospital at the Federal District. Methodology: Patients with a previous diagnosis of BC, in treatment or follow-up at our PH service, were evaluated for the risk of hereditary BC from January to March 2021. Patients who fulfilled criteria for genetic testing, according to the National Comprehensive Cancer Network (NCCN) criteria (version 1.2020), were defined as at risk of h
APA, Harvard, Vancouver, ISO, and other styles
6

Freitas, Laura Rabelo de, Lilian Cristina Silva da Costa, Maria Gabriela Ferreira da Silva, Luiza Rodrigues Batista, and Rafael Henrique Szywanski Machado. "EPIDEMIOLOGICAL CHARACTERISTICS AND INCIDENCE OF BREAST CANCER IN MALE PATIENTS IN A TERTIARY HEALTH INSTITUTION." In XXIV Congresso Brasileiro de Mastologia. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s1030.

Full text
Abstract:
Introduction: Despite the rare incidence of malignant breast pathologies in men, it is extremely important to pay attention to any complaints related to breast alterations in men. Benign and malignant breast diseases are uncommon in men. In addition, most of the male population can be careless when it comes to their own health, especially in breast diseases, commonly seen as an exclusive condition for women. Objective: The aim of this study was to analyze the epidemiological profile of male patients treated at the Mastology Clinic in Rio de Janeiro, Lagoa’s Federal Hospital (HFL), a tertiary h
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Advanced prostatic carcinoma' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography